Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017010587> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2017010587 endingPage "3157" @default.
- W2017010587 startingPage "3157" @default.
- W2017010587 abstract "Abstract Ovarian cancer is a leading cause of cancer death in women, is usually diagnosed in late stage, and currently has insufficient effective targeted therapies. The primary mode of metastasis is unique in that dissemination occurs via tumor cell shedding into the peritoneal cavity, survival and growth within ascites, and re-adhesion and proliferation of tumor cells at sites within the abdomen. Therefore, molecules and pathways involving cell adhesion and survival in non-adherent environments are of particular interest. Rgnef (p190RhoGEF/Arhgef28) is a Rho family guanine exchange factor that associates with focal adhesion kinase (FAK) and functions both as a downstream target of FAK tyrosine kinase activity and a regulator of FAK activity following integrin stimulation. FAK regulates cell adhesion, migration, and survival. Expression of FAK is associated with poor clinical outcome, its activity (as measured by FAK Y397 phosphorylation) is frequently increased in serous ovarian carcinomas, and it is currently under investigation as a therapeutic target in ongoing clinical trials. Immunohistochemical analysis of human tumor tissue arrays with antibodies specific for Rgnef and FAK pY397 reveal a positive correlation between Rgnef expression and FAK activation and increased stage/grade of serous-type ovarian cancer. Stable knockdown of Rgnef in human ovarian carcinoma cells grown as subcutaneous or intraperitoneal xenografts in mice suggest that Rgnef may play roles in both primary tumor growth and ascites-associated cell survival and spread. Here, we use a transgenic model of spontaneous ovarian cancer (MISIIR-T-Antigen) to test the role of Rgnef in ovarian cancer progression. Female Rgnef+/+;TAg+ and Rgnef-/-;TAg+ mice were monitored by ultrasound imaging from age 12 to 17 weeks before euthanasia. Rgnef-/-;TAg+ tumors were significantly smaller (p=0.0006) and contained fewer Ki67 positive cells than Rgnef+/+;TAg+ controls at 17 weeks. Tumors and ovarian carcinoma cells isolated from Rgnef-/-;TAg+ mouse ascites have reduced FAK pY397 and increased E-cadherin expression compared to controls, suggesting that loss of Rgnef results in a less aggressive tumor phenotype. These findings identify Rgnef as a component in signaling pathways promoting FAK activation and regulating ovarian tumor progression. Citation Format: Nichol L. G. Miller, Isabelle Tancioni, Sean Uryu, Elizabeth G. Kleinschmidt, Denise C. Connolly, David D. Schlaepfer. An Rgnef (p190RhoGEF/Arhgef28) signaling axis regulates ovarian cancer progression. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3157. doi:10.1158/1538-7445.AM2014-3157" @default.
- W2017010587 created "2016-06-24" @default.
- W2017010587 creator A5006342431 @default.
- W2017010587 creator A5006498849 @default.
- W2017010587 creator A5040691385 @default.
- W2017010587 creator A5058150315 @default.
- W2017010587 creator A5081651835 @default.
- W2017010587 creator A5090973852 @default.
- W2017010587 date "2014-10-01" @default.
- W2017010587 modified "2023-09-24" @default.
- W2017010587 title "Abstract 3157: An Rgnef (p190RhoGEF/Arhgef28) signaling axis regulates ovarian cancer progression" @default.
- W2017010587 doi "https://doi.org/10.1158/1538-7445.am2014-3157" @default.
- W2017010587 hasPublicationYear "2014" @default.
- W2017010587 type Work @default.
- W2017010587 sameAs 2017010587 @default.
- W2017010587 citedByCount "2" @default.
- W2017010587 countsByYear W20170105872018 @default.
- W2017010587 countsByYear W20170105872019 @default.
- W2017010587 crossrefType "journal-article" @default.
- W2017010587 hasAuthorship W2017010587A5006342431 @default.
- W2017010587 hasAuthorship W2017010587A5006498849 @default.
- W2017010587 hasAuthorship W2017010587A5040691385 @default.
- W2017010587 hasAuthorship W2017010587A5058150315 @default.
- W2017010587 hasAuthorship W2017010587A5081651835 @default.
- W2017010587 hasAuthorship W2017010587A5090973852 @default.
- W2017010587 hasConcept C108636557 @default.
- W2017010587 hasConcept C121608353 @default.
- W2017010587 hasConcept C126322002 @default.
- W2017010587 hasConcept C142724271 @default.
- W2017010587 hasConcept C150173356 @default.
- W2017010587 hasConcept C151166631 @default.
- W2017010587 hasConcept C2779013556 @default.
- W2017010587 hasConcept C2779256057 @default.
- W2017010587 hasConcept C2780427987 @default.
- W2017010587 hasConcept C3019054536 @default.
- W2017010587 hasConcept C502942594 @default.
- W2017010587 hasConcept C62478195 @default.
- W2017010587 hasConcept C71924100 @default.
- W2017010587 hasConcept C86803240 @default.
- W2017010587 hasConcept C95444343 @default.
- W2017010587 hasConceptScore W2017010587C108636557 @default.
- W2017010587 hasConceptScore W2017010587C121608353 @default.
- W2017010587 hasConceptScore W2017010587C126322002 @default.
- W2017010587 hasConceptScore W2017010587C142724271 @default.
- W2017010587 hasConceptScore W2017010587C150173356 @default.
- W2017010587 hasConceptScore W2017010587C151166631 @default.
- W2017010587 hasConceptScore W2017010587C2779013556 @default.
- W2017010587 hasConceptScore W2017010587C2779256057 @default.
- W2017010587 hasConceptScore W2017010587C2780427987 @default.
- W2017010587 hasConceptScore W2017010587C3019054536 @default.
- W2017010587 hasConceptScore W2017010587C502942594 @default.
- W2017010587 hasConceptScore W2017010587C62478195 @default.
- W2017010587 hasConceptScore W2017010587C71924100 @default.
- W2017010587 hasConceptScore W2017010587C86803240 @default.
- W2017010587 hasConceptScore W2017010587C95444343 @default.
- W2017010587 hasIssue "19_Supplement" @default.
- W2017010587 hasLocation W20170105871 @default.
- W2017010587 hasOpenAccess W2017010587 @default.
- W2017010587 hasPrimaryLocation W20170105871 @default.
- W2017010587 hasRelatedWork W1554390018 @default.
- W2017010587 hasRelatedWork W1967434444 @default.
- W2017010587 hasRelatedWork W2062429284 @default.
- W2017010587 hasRelatedWork W2087126635 @default.
- W2017010587 hasRelatedWork W2168388492 @default.
- W2017010587 hasRelatedWork W2337105312 @default.
- W2017010587 hasRelatedWork W2623381579 @default.
- W2017010587 hasRelatedWork W2887687842 @default.
- W2017010587 hasRelatedWork W3004978053 @default.
- W2017010587 hasRelatedWork W3021510746 @default.
- W2017010587 hasVolume "74" @default.
- W2017010587 isParatext "false" @default.
- W2017010587 isRetracted "false" @default.
- W2017010587 magId "2017010587" @default.
- W2017010587 workType "article" @default.